(Q48626875)

13 February 2018

title

Prospective study on the relationship between infections and multiple sclerosis exacerbations. (English)

1 reference

13 February 2018

0 references

Buljevac D

1

1 reference

13 February 2018

Flach HZ

2

1 reference

13 February 2018

Hop WC

3

1 reference

13 February 2018

Hijdra D

4

1 reference

13 February 2018

Laman JD

5

1 reference

13 February 2018

Savelkoul HF

6

1 reference

13 February 2018

van Der Meché FG

7

1 reference

13 February 2018

van Doorn PA

8

1 reference

13 February 2018

Hintzen RQ

9

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 May 2002

1 reference

13 February 2018

published in

Brain

1 reference

13 February 2018

volume

125

1 reference

13 February 2018

page(s)

952-960

1 reference

13 February 2018

issue

Pt 5

1 reference

13 February 2018

APOE genotype is a major predictor of long-term progression of disability in MS

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

A serial study of new MS lesions and the white matter from which they arise

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

The genetic analysis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Clinical viral infections and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Axonal pathology in multiple sclerosis: relationship to neurologic disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Susceptibility to multiple sclerosis: interplay between genes and environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Genetics of multiple sclerosis [published erratum appears in Hum Mol Genet 1997 Nov;6(12):2189]

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Relapses and progression of disability in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Th-cell modulation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Balancing the Th1/Th2 concept in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Serial magnetic resonance imaging studies with paramagnetic contrast medium: assessment of disease activity in patients with multiple sclerosis before and after influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Influence of infection on exacerbations of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF098

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWF098

1 reference

13 February 2018

PubMed ID

11960885

1 reference

13 February 2018